Boise State University

ScholarWorks
Genetic Counseling Faculty Publications and
Presentations

Department of Genetic Counseling

10-2020

Facing the Challenge of Genetic Counselors' Need for Rapid
Continuing Education About Genomic Technologies
Kelly D. Farwell Hagman
Ambry Genetics

Devon Lamb Thrush
Ambry Genetics

Samantha Freeze
InformedDNA

Darnelle L. Dorsainville
GeneDx

Jennifer Eichmeyer
Boise State University

See next page for additional authors

This is an author-produced, peer-reviewed version of this article. The final, definitive version of this document can
be found online at Journal of Genetic Counseling, published by Wiley on behalf of the National Society of Genetic
Counselors. Copyright restrictions may apply. https://doi.org/10.1002/jgc4.1213. The content of this document
may vary from the final published version.

Authors
Kelly D. Farwell Hagman, Devon Lamb Thrush, Samantha Freeze, Darnelle L. Dorsainville, Jennifer
Eichmeyer, Kimberly C. Banks, and Genomic Technologies Special Interest Group of the National Society
of Genetic Counselors

This article is available at ScholarWorks: https://scholarworks.boisestate.edu/genetic_facpubs/1

This is an author-produced, peer-reviewed version of this article. The final, definitive version of this document can be found online at Journal of
Genetic Counseling, published by Wiley. Copyright restrictions may apply. https://doi.org/10.1002/jgc4.1213

Facing the Challenge of Genetic Counselors’ Need for Rapid
Continuing Education About Genomic Technologies
Kelly D. Farwell Hagman*
Ambry Genetics
Department of Clinical Genomics
Aliso Viejo, CA
kfarwell@ambrygen.com
Devon Lamb Thrush
Ambry Genetics
Department of Clinical Genomics
Aliso Viejo, CA
Samantha Freeze
InformedDNA
St. Petersburg, FL
Darnelle L. Dorsainville
GeneDx
Gaithersburg, MD
Jennifer Eichmeyer
Boise State University
Boise, ID
Kimberly C. Banks
(on behalf of the Genomic Technologies Special Interest Group of the National Society of Genetic Counselors)
Guardant Health
Department of Medical Affairs
Redwood City, CA
Abstract
The last couple of decades have seen the rapid advancement of genomic technologies (GT) and
their equally rapid adoption into clinical testing. Regardless of specialty, all genetic counselors
are unified by the fundamental goal to aid in diagnosing patient’s genetic disease underscoring
the importance for genetic counselors to maintain an in-depth understanding of GT. The National
Society of Genetic Counselors’ (NSGC) GT Special Interest Group conducted an online survey
of NSGC members to assess current genomic technologies knowledge gaps. A total of 171
individuals from a variety of primary work settings completed the survey sufficiently to be
included in the analysis. The majority of respondents received their degree in genetic counseling
in more recent years (2000 – 2015). On average across all technologies, >70% of respondents
deemed knowledge of GTs as important for successful job performance, 55% responded that
additional job training in GTs is needed to successfully perform job functions, and only 28%
responded that graduate training in GTs was good. Overall, the data show that participating
genetic counselors perceive that their knowledge of GTs is inadequate while it is a key
component of their jobs. These results have implications both for training programs and for
continuing education efforts. These data can be used as a starting point for additional research
into GT educational needs of genetic counselors.
Keywords: genomic technologies, genetic counselor education, needs assessment, continuing education, Next-Gen
Sequencing (NGS)
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Introduction
The last several decades has seen an explosion in new and emerging genomic technologies (Cunha, 2017; Galas &
McCormack, 2003) making the need for continuing education for genetic counselors a constant and difficult task.
Additionally, the past decade has seen an unprecedented expansion in roles of genetic counselors outside of the
traditional patient-counselor clinical role to settings such as laboratory, research, marketing, insurance, and
bioinformatics (Christian, Lilley, Hume, Scott, & Somerville, 2012; McWalter et al., 2018; Radford, Prince, Lewis,
& Pal, 2014; Swanson, Ramos, & Snyder, 2014; Wain, 2018; Zetzsche, Kotzer, & Wain, 2014). In fact, it is anticipated
that genetic counselors will sit on the frontline of precision health given that genetic counseling “is technology-driven
and an individual-centered approach, exactly the same properties of what is now called ‘precision medicine’”
(Bamshad, Magoulas, & Dent, 2018). Starting as early as 2012, discussion emerged about how genetic counselors
can adequately incorporate next-generation sequencing (NGS) into clinical practice (Hooker, Ormond, Sweet, &
Biesecker, 2014; Roche, 2012; Wicklund & Trepanier, 2014).
Regardless of practice specialty, genetic counselors are unified by the fundamental goal to aid in diagnosing a patient’s
genetic disease. The first domain of the core competencies for genetic counselors trained in United States/Canadian
accredited programs that “an entry-level provider must demonstrate to successfully practice as a genetic counselor” is
titled "genetics expertise and analysis” (www.gceducation.org/practice-based-competencies/). Specifically, a genetic
counselor should “demonstrate and utilize a depth and breadth of understanding and knowledge of genetics and
genomics core concepts and principles” including applying this knowledge to “genetic testing and test report
interpretation.” Interpretation of genetic test results requires a basic understanding of the underlying technologies and
these tests typically use the most recent and emerging technologies. Further, as direct to consumer (DTC) offerings
continue to gain popularity, genetic counselors will be called upon to help interpret the results. A recent study showed
that up to 40% of variants identified in DTC testing are false positives, generally due to limitations in the particular
technologies used (Tandy-Connor et al., 2018). Therefore, it is imperative that genetic counselors maintain a clear and
thorough understanding of genomic technologies (GT) and that efforts be made by graduate school programs and
governing organizations to assist in GT continuing education.
There has been ample discussion about genetics education of non-genetics health care providers (Baars, Henneman,
& Ten Kate, 2005; Blaine et al., 2008; Farndon & Bennett, 2008; Gaff, Williams, & McInerney, 2008; Hunter, Wright,
Cappelli, Kasaboski, & Surh, 1998; Kirk, Tonkin, & Burke, 2008; Masny, Ropka, Peterson, Fetzer, & Daly, 2008;
Metcalfe, Haydon, Bennett, & Farndon, 2008; Suchard, Yudkin, Sinsheimer, & Fowler, 1999). In fact, a systematic
review of the literature relating to primary care providers’ perceived barriers against provision of genetic services
found that knowledge about genetics and genetic risk assessment was among the top four most common barriers
(Mikat-Stevens, Larson, & Tarini, 2015). In 2010, Calzone et al. detail the need for providing genomic/genetic
education for nurses in order to facilitate the ability of the United States health care system to better promote health
and manage disease (Calzone et al., 2010). In the current study, we aimed to assess whether further genetics education
is needed even among genetic counselors. Specifically, we aimed to assess current genomic technologies knowledge
gaps of practicing genetic counselors.
Methods
Participants and Procedures
The GT Special Interest Group (SIG) of the National Society of Genetic Counselors (NSGC) created an electronic
survey using SurveyMonkey® and distributed it to the NSGC membership via multiple mechanisms in March and
April 2016: NSGC “Link” monthly member e-newsletter on March 11, 2016; discussion forums of NSGC SIGs via
SIG chairs on March 22, 2016; NSGC general “all members” discussion forum on April 7, 2016. It is estimated that
the survey was sent to approximately 4,000 individuals via these methods. Confirmation of distribution was received
from the Health Information Technology and Neurogenetics SIG chairs. Prior to administration of the survey, the GT
SIG chairs verbally alerted various members about the anticipated survey and encouraged participation. The survey
remained open until May 1st, 2016 (Supplemental Table 1) and no reminder emails were delivered. Any NSGC
member was eligible to take the survey, regardless of specialty, board-certification, or current practicing status. The
research is exempt from the Office for Human Research Protections Regulations for the Protection of Human Subjects
under category 46.104(A).
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Instrumentation
We developed a questionnaire to assess current GT knowledge gaps (Supplemental Table 1). The authors reviewed
the underlying technologies used among commonly available genetic tests on the market at the time of the study and
identified twelve core technologies. These twelve core GTs are listed in Figure 1. The questionnaire contained three
questions about each core technology, demographic items, and a comment section. The three core technologies
questions gauged the participants’ assessment of how important each of the core technologies is to successful job
performance (Likert-type scale: 1 = Not important, 5 - Very important), how much additional training is need to
adequately and successfully perform his/her current job (Likert-type scale: 1 = No training needed, 4 = A high level
of training needed), and how adequate the level of education obtained during graduate school was (Likert-type scale:
1 = Very poor, 5 = Very good, 0 = N/A, no training received, respondents who selected N/A were removed from
analyses of this item). The demographics section assessed the primary work setting, specialty, and year of graduation
from graduate training in genetic counseling.
Data Analysis
Descriptive statistics were calculated for each survey response. Respondents could choose multiple specialties, and
specialty distribution among respondents was compared to the 2016 professional status survey (PSS;
https://www.nsgc.org/d/do/6432) specialty distribution using one-way ANOVA to determine if representation of the
greater membership was obtained. Specialty was not used in the analysis of responses to the three core technology
questions. Instead, respondents were classified by primary work setting into one of three categories: clinical,
laboratory, or other (Table 1). Pairwise comparisons using Fisher’s exact 2x2 2-tailed contingency calculations were
performed to compare responses for each technology by primary work setting; specifically, responses by participants
from a clinical specialty were compared to those from a laboratory setting and to those from an “other” setting and
participants from a laboratory setting were compared to those from an “other” setting. For the query regarding
graduate school training, respondents who selected N/A—no training received were removed from the statistical
calculations. Free text response data were analyzed using an inductive thematic analysis and basic descriptive
statistics. Each free text response was evaluated by a single coder (SF) who generated and assigned initial themes to
each response. Initial themes were then reviewed for agreement by a second coder (KB) who generated and assigned
master themes to further categorize the free text responses. Both coders provided final review and reconciliation of
the initial and master themes and were in agreement with final coded data set. Only the percentage of total respondents
who contributed free text responses for each thematic category was reported. Inter-rater agreement (kappa statistic
and p-value) were not calculated.
Results
Demographics
A total of 183 individuals responded to the survey. The response rate is estimated to be 4.6% (183/~4,000). Twelve
surveys included no response to all twelve queries for at least one of the three main GT questions and were therefore
eliminated from further analysis, resulting in 171 surveys included in data analysis. These 171 participants worked
primarily in clinical settings (52%) followed by laboratory settings (36%) (Table 1). Most respondents (83%)
graduated from a genetic counseling master’s program 2000-2015 (Table 1, Supplemental Figure 1). The distribution
of respondents per graduation year was not significantly different from the graduation year distribution among 2016
NSGC PSS respondents (p=0.63). The respondents’ reported specialty also did not differ from the 2016 PSS (p= 0.89).
Further, there was no difference in the distribution of graduation years based on work setting (clinical, laboratory,
other) (p=0.65). Survey respondents could choose more than one specialty; the most common specialties were cancer
(93 respondents; 54%), genetic testing (43 respondents; 25%), prenatal (30 respondents; 17.5%), laboratory (28
respondents; 16%), and general genetics (24 respondents; 14%).
Genomic Technologies Knowledge and Needs
Across the twelve GT categories, the percentage of respondents who reported that knowledge of the technologies is
“important” or “somewhat important” in order to successfully perform his/her job ranged from 46.2% to 98.8%
(average = 73.5%) (Table 2, Figure 1). NGS ranked the highest with 98.8% identifying it as important for job
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performance, followed by Sanger Sequencing (94.2%), cfDNA-tumor (93%), and PGS/PGD (84.2%). The lowest
ranked technology was bioinformatics, yet still almost half of respondents deemed it important for successful job
performance (46.2%).
Across the twelve GT categories, the percentage of respondents who reported that “some training” or “a high level of
training” is needed for adequate job performance ranged from 28.2% to 76.9% (average =54.9%) (Table 2, Figure 1).
Ranked the highest in need of training were cfDNA-tumor (76.9%), NGS-based CNV detection (75.1%), PGS/PGD
(74.7%), and PCR/DNA amplification (72.2%). The lowest ranked technology was on-array capture methods,
however nearly a third of respondents (28.2%) indicated that further training is needed on this technology. In addition,
28.6% of respondents who provided free text comments (14/49) and suggestions expressed a desire for additional
training regarding specific genomic technologies.
Overall across the twelve GT categories, only an average of 28.1% of respondents reported that graduate school
training in the GTs was either “good” or “very good.” (Table 2, Figure 1). Further, 28.6% of free text comments and
suggestions expressed a personal or perceived impression that graduate school training in GTs did not meet what
respondents viewed as adequate for job performance. The technologies which ranked the lowest in terms of having
received good/very good training in graduate school were cfDNA-tumor (2.9%), in-solution capture methods (5.3%),
bioinformatics (8.8%), and on-array capture methods (10.5%). Although not the lowest ranking, a minority of
respondents reported good/very good training for NGS-based CNV detection (16.4%), NIPT/NIPS (18.1%), NGS
(23.4%), or MLPA (30.4%). The technology ranked the best in terms of graduate school training was Sanger
Sequencing (68.4%) followed by PCR/DNA amplification (66.1%), arrayCGH (39.8%), and PGD/PGS (47.4%).
NGS was ranked the most important technology needed for successful job performance (98.8%), yet 43% of
respondents reported that additional training is needed for adequate job performance and only 23% felt that graduate
school training was good/very good. Those that reported inadequate training in NGS clustered in the earlier graduating
classes (Table 3).
The technology which emerged as the most discrepant with regard to importance for job
performance versus training needed was cfDNA-tumor with 93% of respondents reporting that the technology is
important for successful job performance, yet 76.9% feel additional training is needed and only 2.9% felt that graduate
school training was sufficient.
Differences by Primary Work Setting
Participants from a laboratory setting were significantly more likely to deem bioinformatics, aCGH, and PGS/PGD
important for successful job performance as compared to participants from a clinical setting (p<0.01; Table 2).
Conversely, participants from a clinical setting were significantly more likely to deem in-solution sequence capture
methods important to successful job performance as compared to participants from a laboratory setting (p<0.01).
Participants from a clinical setting felt that graduate school training in NGS-based copy-number variation (CNV)
detection was good as compared to participants from a laboratory setting (p<0.01). Participants from the nonclinical/non-laboratory (aka “other”) setting felt that more training is needed in MLPA as compared to individuals in
a laboratory setting (p<0.01). No other statistically significant differences by primary work setting were identified.
Graduate School Training by Year of Graduation
The level of reported training improved with more recent graduates. Across all twelve technologies, 93.9% graduates
from the earliest group (1979-1989) felt that graduate school training was inadequate or that they did not receive
training (Table 3, Supplemental Figure 2). Among graduates from 1990-1999, 2000-2009, and 2010-2015, 86.6%,
62.9%, and 37.4% felt that training was inadequate or that they did not receive training, respectively. Even among
the most recent graduates (2010-2015), 37.4% reported that training was “poor,” “very poor,” or absent on average
across all technologies. The four technologies that ranked the poorest among recent graduates were NIPT/NIPS, insolution sequence capture methods, bioinformatics, and cfDNA-tumor with 79.2%, 71.8%, 60%, and 38.9% of the
respondents stating that training was inadequate or absent, respectively.
Qualitative Analyses of Free Text Comments and Suggestions
Of the 171 respondent surveys included in data analysis, 55 (32%) provided supplemental free text comments and/or
suggestions (Supplemental Table 2). Six of these responses were too brief to perform qualitative thematic analysis.
The responses were comprised of mostly 1-2 sentence short answers intended to provide context to the respondent’s
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survey answers or provide a suggestion for additional GT training preferences. Of the 49 remaining participant
responses, 10 key minor themes were identified (Table 4). These themes were then categorized into three higher
themes; (1) training theme, (2) comparison ability theme and (3) other theme. The training theme was applied to
responses where respondents indicated an impression about previously received training or the need/desire for
additional GT training. The comparison ability theme was applied to responses where the respondent indicated a
need/desire for additional training in how to evaluate appropriateness of various GTs and/or the ability to compare
genetic testing laboratories and how to choose the “best” lab for their clinical needs. The other theme was applied to
responses with low reporting percentage but that the researchers felt were valuable to overall interpretation of genetic
counselor attitudes towards GT training. Overall, responses focused heavily on the themes of perception of inadequate
genetic counselor training for GTs (13/49; 26.5%), the desire for additional training regarding specific GTs (14/49;
28.6%) and how to evaluate the clinical appropriateness of various GTs and GT platforms (14/49; 28.6%).
Some genetic counselors also indicated in free text responses the desire for additional training in specific genomic
technologies. However, they also expressed the desire for less theoretical information and more practical education
focused on information that can be applied in their clinical practice. For instance, one respondent stated that, during
graduate school, she/he received “some education [regarding GTs], but at the time didn't know what was important
for everyday use and what was background education, areas of importance are more clear now that I am in practice.”
This quote also reflects an additional theme of “on-the-job training” where respondents indicated a personal or
perceived impression that the most useful education regarding GTs was gained after graduate school and during his/her
career and in collaboration with other genetic counselors.
Discussion
In a commentary on genetic counseling in the genomic era, Wicklund and Trepanier state: “As new technology is
adopted, it is critically important for program directors and practicing professionals to evaluate whether fundamental
changes in genetic counselors’ knowledge, skills, and attitudes, and ultimately genetic counseling practice are
required” (Wicklund & Trepanier, 2014). In this study, we provide quantitative data addressing these needs which
demonstrate that indeed fundamental changes may be warranted.
The consistent rapid expansion of genomic technologies has led to the need for continuing education for genetic
counselors. These survey data represent the first study to investigate genetic counselor self-assessment regarding GT
knowledge gaps and training needs. The majority of respondents, across all specialties reported that knowledge of the
core GTs is important for successful job performance, that additional training is needed, and that graduate school
training was not adequate. Responses to this survey indicate that baseline education about genomic technologies via
graduate programs is limited, which is not unexpected given the breadth of required and necessary medical genetics
and clinical/psychosocial skills covered in the two-year masters’ programs and the fast pace of implementation of new
technologies. Genetic counseling program directors report that genomic medicine is either currently taught or under
development and rank genomic technologies among the most important to include in genetic counseling curricula
(Profato, Gordon, Dixon, & Kwan, 2014). These data can serve to aid in shaping the training program curricula related
to GTs. However, overall the data likely reflect the rapidly advancing and evolving molecular technologies which can
more adequately and contemporaneously addressed via ongoing education opportunities. Webinars in particular offer
rapid, up-to-date, low-cost opportunities for continuing education.
These results provide insight for both graduate school curricula and for continuing education outlets. For example,
cell free analysis of tumor DNA emerged as the most immediate need given it scored lowest with regard to graduate
school training but scored among the highest among knowledge most needed for successful job performance.
Likewise, the technology that ranked the highest in importance for job performance was NGS, with 98.8% of
respondents identifying this technology as important, yet less than a quarter felt that graduate school training on the
topic was good/very good. Although only 43% identified that some/significant training in NGS is needed to more
adequately perform their job, the overall importance for job performance and limited baseline training suggest that
adjustments to future graduate curricula and greater allocation of continuing education resources to this topic would
serve the genetic counseling community well.
Some differences were observed among counselors based on primary work setting. While at least two-thirds of
laboratory counselors and clinical counselors felt that some training was needed to understand aCGH and PGS/PDG
technologies, laboratory counselors were significantly more likely to report that understanding aCGH and PGS/PDG
technologies were more important to successful job performance than clinical counselors. This result suggests that on-
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the-job training in these technologies is more important for genetic counselors working in the laboratory setting.
While laboratory counselors were significantly more likely to report bioinformatics more important to successful job
performance than clinical counselors, bioinformatics scored among the lowest with regard to graduate school training.
Bioinformatics is the tool used to analyze all genetic data; it is the language that translates the raw genetic data to
understandable concepts and is therefore arguably the most important of any of the core technologies. This finding
argues for improvement in education in bioinformatics in genetic counseling curricula and continuing education
outlets, or that bioinformatics should be part of the standard onboarding training by diagnostic laboratories hiring
genetic counselors.
Clinical genetic counselors were significantly more likely to feel that in-solution sequence capture methods were
important for job performance compared to laboratory counselors. This finding may indicate that clinical counselors
feel that complete knowledge of the strengths and limitations of capture methods and how they may influence gene
coverage is necessary for proper patient counseling. On the other hand, it is possible that laboratory genetic counselors
did not rank these technologies as important because they feel they are adequately trained in these methods which are
commonly used by most diagnostic laboratories.
It stands to reason that genetic counselors in laboratory settings need to have in-depth knowledge of laboratory
techniques. This study identified that fewer participants from the laboratory setting felt that graduate school training
in NGS-based copy-number variation (CNV) detection was good compared to participants in the clinical setting. It is
possible that this result is identifying laboratory genetic counselors’ greater need for very nuanced and detailed
understanding of this laboratory technology compared to clinical genetic counselors and in this regard the level of
graduate school training for this GT was more suitable for clinical settings than laboratory settings.
It is interesting that most of the statistical analyses comparing laboratory, clinical, and other job settings did not reveal
significance (Table 2). One might expect laboratory counselors to feel more knowledgeable about GT technologies.
However, laboratory counselors work in a variety of settings (clinical reporting, research, marketing, accessioning,
etc) and it is possible that some may have even less exposure to technologies than clinical counselors. Further, it is
possible that the distinction in knowledge between laboratory and clinical counselors is blurred by the recent growth
in the proportion of laboratory counselors in the workforce, many of whom spent the better part of their careers in the
clinic.
Respondents from more recent graduating classes felt that graduate school training of GT was more adequate
compared with respondents from the most senior graduating classes, who felt that training in virtually all of the
technologies was poor or absent. This finding is expected given that several of the technologies did not exist for the
earlier graduating classes. The data provide a glimpse into the education received among current, working genetic
counselor professionals in a field that is rapidly advancing. Even among the classic genomic technologies of
PCR/DNA amplification and Sanger Sequencing, over half of participants from the most senior graduating classes
responded that training was inadequate. Despite these relative differences, it is worth noting that even among the most
recent graduates roughly one-third reported that training was inadequate on average across all technologies. The
desire for additional and on-going training opportunities regarding emerging GTs was expressed in respondent free
text comments and suggestions as well. It appears that some respondents felt that rapid technology development is
outpacing the ability for genetic counselors to obtain adequate training for appropriate and responsible use of emerging
GTs in the clinic.
These data may also reflect a true paradigm shift in the scope of practice for genetic counseling in the United States
and Canada The field of genetic counseling grew from a primarily prenatal specialty with far more attention on the
psychosocial skill development as GT was comparatively simple, with fewer testing options. Although the data here
indicate that GT education was inadequately met in earlier years, the need for in-depth understanding of a variety of
GTs was also not quite as involved as it is currently. Now, with so many more technology options and expanding
knowledge of molecular genetics, the need for genetic counselors to translate this complex information into practical
clinical applications has grown and strategies to support this need must be developed.
One strategy for adapting to the need for in-depth understanding of clinical molecular diagnostic technologies involves
genetic counselor specialization, where clinical counselors can leverage the knowledge of their laboratory colleagues
when technical complexities arise and laboratory counselors can leverage counseling expertise of the clinical
counselors. Another strategy is to lengthen the two-year genetic counseling program and/or develop specialization
certifications. Benefits of a doctoral degree in genetic counseling have been presented since the 1980s (Scott, Walker,
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Eunpu, & Djurdjinovic, 1988) and early studies showed that most genetic counselors supported a doctoral degree in
genetic counseling (Gaupman, Edwards, Brooks, & Young, 1991). More recently, a 2015 survey assessing the
attitudes of genetic counselors around the shifting of genetic counseling education to a clinical doctorate (ClinD)
reported that most genetic counselors prefer to maintain the master’s degree route (Nagy et al., 2015) and employees
have concerns about the economic viability of a ClinD (Valverde, Mueller, Paciotti, & Conway, 2016). Notably
however, graduates from 2009-2012, who would have had the most exposure to newer and emerging GTs in that
sample, were in favor of the ClinD significantly more than earlier graduating classes. Additional studies show that a
majority of genetic counseling program directors are in favor of the transition to the clinical doctorate (Stuenkel,
Campion, Allain, & Hampel, 2012) and genetic counselors who already have doctoral degrees (PhD) see benefit to
doctoral training in genetic counseling (Atzinger et al., 2007). Additionally, for a few measures in this present study,
there is a divergence in terms of knowledge needs for clinical versus non-clinical genetic counselors. Perhaps an
additional year would allow students to focus and have more time to develop the skills necessary for a particular
specialty. Some training programs may also welcome the opportunity to have more space to teach new material while
still honoring the relevant history of this profession.
One of the difficulties faced by training programs is trying to incorporate the new knowledge with the old. There is a
far greater volume of genetic information today than even in recent years, and this body of knowledge will only
continue to grow. It can be incredibly cumbersome and time consuming for academic institutions to continuously
update curricula especially with subjects that are rapidly changing and become outdated in such little time.
Furthermore, writing and validating questions for the national American Board of Genetic Counseling (ABGC)
certification exam content also requires considerable time and effort. As a result, there may be required topics in
genetic counseling training that center on longstanding practices that have become less emphasized in practice but
need to be covered due to the challenges of quickly update curricula and ABGC proficiency standards. As a profession,
it may be worth evaluating a new model for reviewing and deploying education standards in a manner that can keep
up with a technologically advanced discipline like genetic counseling. In a thoughtful commentary, Hooker, et al.
provide a diversity of approaches to maximizing genetic counseling education to include genomic medicine (Hooker
et al., 2014).
In addition, it may be worthwhile to explore other methods for educating students through online technology solutions
or multi-program collaborations. For example, training programs could adopt the same learning module, developed
and shared with all ACGC accredited programs, on an emerging topic thus saving the same effort in creating similar
content across the >40 currently accredited programs. More discussion would be necessary on the financial aspects of
shared curriculum and tuition, but there may be opportunities to create some efficiency and standardization in genetic
counseling training.
Given the rapid emergence of new genomic technologies and their equally rapid application to clinical testing, it is
not realistic to expect graduate schools to provide a complete and thorough education of GT. However, efforts can be
made to assist students with tools needed to continually identify available resources and educate themselves regarding
advancements in newer technologies. As an example, some laboratories are currently offering remote learning
opportunities which often include GT education to graduate students at no cost. Additionally, the results of this survey
may help guide graduate programs in identifying the core genomic technology(s) deemed important for job success
across disciplines. This may require programs to allocate more resources and additional time to ensure adequate
student training.
The main source of continuing education for genetic counselors in the United States, the NSGC Annual Conference,
encompasses a wide variety of topics covering clinical best practices and emerging research, and has gradually
increased the number and depth of sessions provided by laboratories which include elements of genomic technology
education. Interestingly, there was entire education session at the 2015 annual conference dedicated to bioinformatics,
which may partially explain the low perceived need for additional training in bioinformatics found in this survey.
While a great source for continuing GT education, the annual conference cannot suffice alone and additional resources
throughout the rest of the year should be devoted to fill the knowledge gaps. As an example of ongoing GT education
efforts, the NSGC GT SIG was founded in 2015 with the mission to promote the education of genetic counselors and
other health care providers about existing, new, and emerging genetics and genomics technologies. The results of this
survey have directly guided the GT SIG in prioritization of continuing education topics.
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Study Limitations
The survey was sent to the entire NSGC membership listerv and was also distributed to the GT and Cancer SIG
listervs. However, the survey was emphasized within the GT SIG member listerv and some discussion and anticipation
about the survey may have resulted in an overrepresentation of GT SIG members, who are likely to have more
exposure and experience with GT than the general membership. This potential overrepresentation suggests that the
true state of the need for GT education among genetic counselors is actually greater than the results indicate.
The estimated response rate (4.6%) was low, however, the demographics are not statistically significant from the PSS
survey, suggesting that the respondents were representative of the targeted population. However, the small sample
size may have resulted in lack of power to detect statistically significant differences in GT responses across practice
settings.
Another limitation of the study is the lack of a write-in option to potentially identify additional technologies outside
of the twelve core GT or a question about any continuing education that had been received. Additionally, the data
collected are all self-assessments and not based on a quantitative measurement of current knowledge of GT. Further,
the comparison among graduation year may be inherently biased in that the survey was not administered immediately
post-graduation. Those in more recent graduating years may have better recall of their educational experiences than
those who graduated further in the past.
We would also like to point out that the survey was conducted three years ago, and the extent of gaps in knowledge
of GT during the past few years is unknown. These data can be used as a starting point for additional, more in-depth
research into GT educational needs of genetic counselors.
Practice Implications
It is fundamental to the success of a genetic counselor to have a thorough understanding of genetics and genomics
(www.abgc.net/for-diplomates/practice-standards/). These data highlight the need for a more in-depth follow-up
study which addresses the limitations of the current study and that can more adequately reflect the current state of
genetic counseling graduate school education in the United States and Canada. Regardless, these results have
implications for training programs and sources of ongoing education opportunities for genetic counselors as well as
potentially for employers hiring genetic counselors with regard to genomic technology training gaps and opportunities
for continuing education. It is likely that all geneticist, including PhD molecular geneticists and MD clinical geneticists
have the same training needs given the rapid emergence of new technologies. Collaboration between NSGC, the
American College of Medical Genetics, the American Society of Human Genetics, the Association for Molecular
Pathology, and other organizations to offer continuing education would be beneficial.
Conclusion
In this study, we present the first dataset demonstrating genetic counselors’ self-assessment regarding GT knowledge
gaps and training needs. The data show that genetic counselors overall report that their knowledge of GTs is lacking
and yet a key component of their jobs.
Given the continuous, rapid emergence of new genomic technologies, genetic counseling graduate school programs
cannot be expected to provide education in the newest technologies, Rather, programs can provide the fundamental
basis of molecular technologies and prepare students for a career that includes continual learning. Continuing
education efforts should focus heavily on GT. The GT SIG is one example of continuing education efforts. However,
it should be noted that professional organization SIGs may be limited by budgetary constraints. Large-scale continuing
education will likely take a significant coordinated effort by genetic counseling programs, NSGC, and other
organizations (e.g. laboratories).
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Table 1: Respondent Demographics
N

%

89

52.0%

University Medical Center

33

19.3%

Public Hospital/Medical Facility

28

16.4%

Private Hospital/Medical Facility

25

14.6%

Physician's Private Practice

3

1.8%

Laboratory Setting

62

36.3%

Other

20

11.7%

Not-For-Profit Organization

5

2.9%

Research Development/Biotechnology
Company

4

2.3%

Bioinformatics Company

2

1.2%

University/Non-Medical Center

2

1.2%

Internet/Website Company

2

1.2%

Health Maintenance Organization

2

1.2%

Government Organization or Agency

2

1.2%

Private Practice Self-Employed

1

0.6%

1979 - 1989

11

6.4%

1990 - 1999

19

11.1%

2000 - 2009

68

39.8%

2010 - 2015

73

42.7%

Primary Work Setting
Clinical Setting

Graduation Year
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Table 2: Summary of Responses Regarding the Core Technologies by Job Specialty
Deemed important to successful job performancea,d
No. (%)

At least some training needed to successfully
perform jobb,d
No. (%)

Graduate school training was goodc,d
No. (%)

Clinicale

Laboratoy

Otherf

Total

Clinicale

Laboratoy

Otherf

Total

Clinicale

Laboratoy

Otherf

Total

Next-gen sequencing

87 (97.8%)

62 (100%)

20 (100%)

169
(98.8%)

33 (37.9%)

25 (41.0%)

14 (70.0%)

72 (42.9%)

26 (30.2%)

8 (12.9%)

6 (30.0%)

40 (23.4%)

Sanger Sequencing

85 (95.5%)

58 (93.5%)

18 (90.0%)

161
(94.2%)

36 (41.9%)

29 (48.3%)

6 (30.0%)

71 (42.8%)

70 (82.4%)

36 (58.1%)

11 (57.9%)

117
(68.4%)

cell free DNA (cfDNA): Tumor

80 (89.9%)

59 (95.2%)

20 (100%)

159
(93.0%)

68 (78.2%)

44 (71.0%)

18 (90.0%)

130
(76.9%)

1 (1.2%)

3 (4.8%)

1 (5.0%)

5 (2.9%)

Pre-implantation genetic diagnosis/
screening (PGD/PGS)

63
(74.1%)g

60
(98.4%)g

16 (84.2%)

139
(84.2%)

67 (77.9%)

42 (68.9%)

15 (78.9%)

124
(74.7%)

40 (46.5%)

33 (53.2%)

8 (40.0%)

81 (47.4%)

Multiplex Ligation-dependent Probe
Amplification (MLPA)

67 (75.3%)

54 (87.1%)

17 (85.0%)

138
(80.7%)

49 (55.1%)

28
(45.2%)g

17
(85.0%)g

94 (55.0%)

33 (38.4%)

15 (24.2%)

4 (20.0%)

52 (30.4%)

PCR/ DNA amplification

71 (79.8%)

51 (83.6%)

15 (75.0%)

137
(80.6%)

63 (72.4%)

44 (71.0%)

15 (75.0%)

122
(72.2%)

66 (77.6%)

37 (59.7%)

10 (50.0%)

113
(66.1%)

NGS-based copy-number variation (CNV)
detection

64 (74.4%)

51 (83.6%)

17 (85.0%)

132
(79.0%)

66 (75.9%)

45 (72.6%)

16 (80.0%)

127
(75.1%)

21
(24.4%)g

3 (4.9%)g

4 (20.0%)

28 (16.4%)

On-array sequence capture methods

59 (68.6%)

30 (48.4%)

16 (80.0%)

105
(62.5%)

24 (27.0%)

16 (26.2%)

8 (40.0%)

48 (28.2%)

9 (10.6%)

6 (9.8%)

3 (15.0%)

18 (10.5%)

63
(70.8%)g

25
(40.3%)g

13 (68.4%)

101
(59.4%)

48 (54.5%)

33 (53.2%)

14 (70.0%)

95 (55.9%)

5 (5.9%)

3 (4.8%)

1 (5.0%)

9 (5.3%)

Job setting

In-solution sequence capture methods
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cell free DNA (cfDNA): Non-invasive
prenatal testing/screening (NIPT/NIPS)

47 (53.4%)

29 (46.8%)

12 (60.0%)

88 (51.8%)

28 (32.9%)

29 (47.5%)

9 (45.0%)

66 (39.8%)

16 (18.6%)

10 (16.1%)

5 (25.0%)

31 (18.1%)

Comparative genomic hybridization (aCGH)

34
(38.2%)g

42(68.9%)g

11 (55.0%)

87 (51.2%)

59 (67.0%)

40 (65.6%)

14 (70.0%)

113
(66.9%)

39 (45.3%)

21 (34.4%)

8 (40.0%)

68 (39.8%)

Bioinformatics

26
(29.5%)g

43
(70.5%)g

9 (45.0%)

78 (46.2%)

24 (27.3%)

18 (29.5%)

7 (35.0%)

49 (29.0%)

12 (14.5%)

2 (3.2%)

1 (5.0%)

15 (8.8%)

70.6%

76.4%

77.3%

73.5%

54.0%

53.3%

64.1%

54.9%

33.0%

23.9%

26.3%

28.1%

AVERAGE:
a

Response of either "very important" or "somewhat important"

b

Response of either "some training" or "a high level of training- I have no knowledge of this technology"

c

Response of either "very good" or "good"; response of N/A was not included

d

Note that the number of respondents varied per question; the denominator is therefore different for each question

e

University Medical Center, Public or Private Hospital, Private Practice

f

Not-For-Profit Organization, Research Development/Biotechnology Company, Bioinformatics Company, University/Non-Medical Center, Internet/Website Company, Health Maintenance Organization, Government
Organization or Agency, Private Practice Self-Employed
g

p<0.01. (Fisher’s exact 2x2 2-tailed contingency); cells are shaded
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Table 3: Respondents Citing Inadequate Training in Graduate School For Each of the Core Technologies by Year of Graduationa

Graduated 1979 1989 (n=11)

Graduated
1990-1999
(n=19)

Graduated
2000-2009
(n=68)

Graduated
2010-2015
(n=73)

cell free DNA (cfDNA): Non-invasive prenatal testing/screening (NIPT/NIPS)

100.0%

100.0%

98.5%

79.2%

cell free DNA (cfDNA): Tumor

100.0%

100.0%

98.5%

38.9%

In-solution sequence capture methods

100.0%

100.0%

91.0%

71.8%

Next-gen sequencing

100.0%

94.4%

89.6%

29.2%

On-array sequence capture methods

100.0%

94.4%

85.1%

58.6%

NGS-based copy-number variation (CNV) detection

100.0%

94.4%

83.3%

45.8%

Multiplex Ligation-dependent Probe Amplification (MLPA)

100.0%

94.4%

49.3%

27.8%

Comparative genomic hybridization (aCGH)

100.0%

94.4%

48.5%

9.7%

Bioinformatics

100.0%

83.3%

79.1%

60.0%

Pre-implantation genetic diagnosis/ screening (PGD/PGS)

100.0%

55.6%

19.4%

15.3%

PCR/ DNA amplification

72.7%

100.0%

7.5%

7.0%

Sanger Sequencing

54.5%

27.8%

4.5%

5.6%

AVERAGE:

93.9%

86.6%

62.9%

37.4%

a

Response of either "poor," "very poor," or "N/A - didn't receive training"
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Table 4: Respondent Free Text Thematic Analysis
Qualitative Theme Retrieved from
Respondent Free Text

Theme Definition

Respondents’
Reporting N (%)

Specific training

ADesire for additional GT training regarding specific GT (ex: cfDNA, tumor analysis, NGS, WES, WGS, microarray, MLPA, etc). Example:
“I would love to learn about cell free tumor DNA. I never learned it in graduate school and I have recently heard of it at a conference
for the first time.”

14/49 (28.6%)

Lack of training

Personal or perceived impression that GC training programs in general do not meet what they believe to be "standards of education"
on GTs for working GCs. Example: “I definitely think more training is needing during grad school. Even the training I did receive in grad
school was in the theory behind the testing without really applying it to real situation.”

13/49 (26.5%)

Emerging technologies training

Personal or perceived desire for additional and on-going training opportunities to address new and emerging GTs. Example: “I feel very
uneducated about genetic technologies that have come out in the last 5 years.”

9/49 (18.4%)

Practical training

Personal or perceived impression that GT training in GC training programs is not always practical or designed to encompass the
knowledge actually needed for job performance (desire for less theoretical information and more practical application of GT
knowledge) Example: “Had some education [regarding GTs], but at the time didn't know what was important for everyday use and
what was background education, areas of importance are more clear now that I am in practice.”

7/49 (14.3%)

On-the-job training

APersonal or perceived impression that most of the "useful" education about GTs is gained from on-the-job education and learning
from other GCs. “I now work in a commercial laboratory and received most of my higher-level education about genomic technologies
as part of my training for this job. There were very few training opportunities in graduate school or in clinical practice.”

7/49 (14.3%)

Technology comparison

Desire for additional GT training regarding evaluating clinical appropriateness of GTs as well as the differences between different
platforms or different versions of the same GT. Example: “Training on the limitations of the different methods of clinical testing
available would be helpful such as WES vs WGS, MLPA/array vs NGS for del/dup.”

14/49 (28.6%)

Lab comparison

Personal or perceived desire for additional GT training regarding evaluating the strengths/weakness of labs and how to choose the
"best lab" for the specific GT evaluated. Example: “Types of terminology commonly used in methodology section to help ID type of
technology done regardless of the commercial name of the test.”

6/49 (12.2%)

Training Theme

Comparison Ability Theme

16

This is an author-produced, peer-reviewed version of this article. The final, definitive version of this document can be found online at Journal of Genetic Counseling, published by Wiley. Copyright restrictions may apply.
https://doi.org/10.1002/jgc4.1213

Other Theme
Lack of interest

Personal or perceived impression that GCs are generally disinterested in understanding or that GCs are intimidated by their lack of
understanding of GT and therefore do not have an interest in GT. Example: “I need to understand the differences between them, the
limitations and benefits of each, but most of my clients are not interested in having exhaustive detail of the technology, just an
understanding of the significance for them.”

2/49 (4%)

Daunting

Personal or perceived impression that although most GCs desire a more holistic understanding of GT, the complexity and sheer amount
of information is daunting and preventative to seeking out additional training. Example: “Hard for me to follow the new technology.”

2/49 (4%)

Regulation

Desire for additional GT training regarding various regulation principles surrounding GT (ex: FDA regulations, data protection, conflict
of interest for lab GCs, etc.) Example: “Standards regulation including NSGC position and FDA role in regulations.”

1/49 (2%)

cfDNA = cell free DNA, NGS = next-generation sequencing, WES = whole exome sequencing, WGS = whole genome sequencing, MLPA = multiple ligation-depending probe
amplification, GT = genomic technology, GC = genetic counselor
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Figure 1: Heat Map of Knowledge Importance and Training Needs by Genomic Technology (GT)
Genomic Technology

Percent of respondents reporting:

Education
Need
Ranking

Knowledge of GT is
important or
somewhat important
for successful job
performance

Some or significant
training in GT is
needed to more
adequately perform
job

Good or very good
training of GT
received in graduate
school

cell free DNA (cfDNA): Tumor

93.0%

76.9%

2.9%

1

NGS-based copy-number variation
(CNV) detection

79.0%

75.1%

16.4%

2

Pre-implantation genetic diagnosis/
screening (PGD/PGS)

84.2%

74.7%

47.4%

3

In-solution sequence capture

59.4%

55.9%

5.3%

4

Next-generation sequencing

98.8%

42.9%

23.4%

5

Multiplex Ligation-dependent Probe
Amplification (MLPA)

80.7%

55.0%

30.4%

6

Comparative genomic hybridization
(aCGH)

51.2%

66.9%

39.8%

7

Polymerase chain rection (PCR)/ DNA
amplification

80.6%

72.2%

66.1%

8

cell free DNA (cfDNA): Non-invasive
prenatal testing/screening (NIPT/NIPS)

51.8%

39.8%

18.1%

9

On-array sequence capture

62.5%

28.2%

10.5%

10

Sanger Sequencing

94.2%

42.8%

68.4%

11

Bioinformatics

46.2%

29.0%

8.8%

12

Greatest need (highest rate for importance and training need) or gap (<10% received training in grad school)
Next greatest need (knowledge, training need) or gap (15-30% received training in grad school)
3rd group by decreasing rank (knowledge and training need moderate; grad school education received for 4050%)
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